SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $288,000 | -14.0% | 10,496 | +3.8% | 0.01% | -14.3% |
| Q2 2019 | $335,000 | -3.5% | 10,116 | +2.0% | 0.01% | 0.0% |
| Q1 2019 | $347,000 | -2.0% | 9,914 | -6.9% | 0.01% | -12.5% |
| Q4 2018 | $354,000 | -31.1% | 10,645 | +4.3% | 0.02% | -11.1% |
| Q3 2018 | $514,000 | -13.3% | 10,208 | +3.1% | 0.02% | -14.3% |
| Q2 2018 | $593,000 | +21.3% | 9,905 | -7.2% | 0.02% | +23.5% |
| Q1 2018 | $489,000 | +18.1% | 10,676 | +2.7% | 0.02% | +21.4% |
| Q4 2017 | $414,000 | +0.5% | 10,391 | +0.9% | 0.01% | 0.0% |
| Q3 2017 | $412,000 | -27.7% | 10,295 | -22.2% | 0.01% | -33.3% |
| Q2 2017 | $570,000 | +41.1% | 13,231 | +2.4% | 0.02% | +40.0% |
| Q1 2017 | $404,000 | +4.9% | 12,923 | -15.2% | 0.02% | -6.2% |
| Q4 2016 | $385,000 | +1.9% | 15,240 | -0.2% | 0.02% | +6.7% |
| Q3 2016 | $378,000 | +8.0% | 15,276 | -11.2% | 0.02% | 0.0% |
| Q2 2016 | $350,000 | +9.0% | 17,197 | -18.2% | 0.02% | +15.4% |
| Q1 2016 | $321,000 | +15.1% | 21,026 | +5.8% | 0.01% | +18.2% |
| Q3 2015 | $279,000 | – | 19,873 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |